InvestorsHub Logo

DR5

Followers 10
Posts 1118
Boards Moderated 0
Alias Born 01/05/2018

DR5

Re: rodman post# 2213

Tuesday, 03/19/2019 9:58:00 AM

Tuesday, March 19, 2019 9:58:00 AM

Post# of 13869
One possible explanation Rod is that the “non-inferiority” endpoint was met and now they are proving “superiority” to SurgiCel. Excited about our prospects.